Reviva Pharmaceuticals Holdings (RVPH) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Reviva Pharmaceuticals Holdings (RVPH) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Reviva Pharmaceuticals Holdings

· RVPH

Dashboard

Financials

Ratios

Valuation

Statistics

6.254 M

-1.47%

General

Market Cap: $6.25M
Enterprise Value: -$19.75T
Shares Outstanding: 13,110,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -11.58%
ROE: -64.39%
ROIC: -17.05%
Current Ratio: 3.56
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.00
EV/EBITDA: 7.54

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $2.62T
Operating Income: -$2.62T
Net Profit: -$2.45T

Balance Sheet

Cash and Equivalents: $19.89T
Working Capital: $15.21T
Total Assets: $21.14T
Net Debt: -$19.75T
Total Liabilities: $5.93T
Total Equity: $15.21T

Cash Flow Statement (TTM)

Cash Flow from Operations: -$5.92T
Cash Flow from Investing: —
Cash Flow from Financing: $11.37T
Free Cash Flow: -$5.92T
Capital Expenditures: -$4